Novartis has made a dramatic return to the Huntington's disease therapy stage by licensing a candidate from PTC Therapeutics for a whopping $1 billion upfront. The deal – which has a potential total ...

Constant Currency ARR Growth: 8.5% year-over-year. Free Cash Flow Growth: 16% year-over-year, totaling $857 million for fiscal '25. Revenue Contribution from Kepware and ThingWorx: Approximately $200 ...

PTC is selling off its IoT businesses, Kepware and ThingWorx, in order to hone its focus on SaaS and AI, according to CEO Neil Barua, as the conglomerate announced a sale of the operations to asset ...

PTC has evolved into an SaaS-driven industrial software leader with improved profitability, higher margins, and a stronger competitive moat. Growth has been heavily acquisition-driven, raising ...

PTC Therapeutics has long been trying to workshop its vatiquinone into a marketable treatment for Friedreich's ataxia (FA) after a phase 3 fail in 2023. Despite its efforts, the FDA has snubbed the ...

Good afternoon, ladies and gentlemen. Thank you for standing by, and welcome to PTC's 2025 Third Quarter Conference Call. [Operator Instructions] Following the presentation, the conference will be ...

BOSTON, July 30, 2025 /PRNewswire/ -- PTC (NASDAQ: PTC) today announced that it is expanding the scope of its collaboration with NVIDIA, the world leader in accelerated computing. PTC is integrating ...

NEW YORK, July 14 (Reuters) - Design software maker Autodesk (ADSK.O), opens new tab said in a regulatory filing on Monday that it plans to pursue its "strategic priorities" and make only "targeted ...

A former Senior Publishing Editor on the Dow Jones Newswires team at The Wall Street Journal, Aaron earned a Bachelor's degree in Economics from the University of Michigan and a Master's in Journalism ...

Autodesk Inc. is weighing an acquisition of rival engineering-software provider PTC Inc., according to people familiar with the matter. Autodesk has been working with advisers to evaluate a ...